|
|
|
|
|
|
|
|
|
|
Rv2043c More about Rv2043c on TBDB.org More about Rv2043c on TubercuList |
Display all mutations or select a bar from the histogram above to examine in greater detail |
| Rv2043c: Codons 55 to 59: 8 mutations (high confidence mutations are highlighted in yellow) | |||||||||||||||
| Primary reference | Polymorphism | Nucleotide position | Codon position | Amino acid | Time period | Origin | Molecular detection method | Gene coverage | Resistance pattern | MIC | Susceptibility testing method | R/Total isolates | R/S isolates with mutation | Additional mutations | High confidence support |
| Louw GE Int J Tuberc Lung Dis 2006 | CAC/TAC | 169 | 57 | His/Tyr | 2001-2002 | South Africa | Sequencing | Whole gene | ZHRSEthK | - | BACTEC MGIT 960 | 115 | 68 | - | ![]() |
| Sreevatsan S AAC 1997 | CAC/GAC | 169 | 57 | His/Asp | 1996 | Diverse geographical locations | Sequencing | Whole gene | Z | - | BACTEC 460 | 67/118 | 2/0 | - | - |
| Brown TJ JMedMicro 2000 | CAC/CCC | 170 | 57 | His/Pro | 2000 | Turkey | Sequencing | Whole gene | ZHRP | - | "BACTEC radiometric-based culture method, standard protocol; and PZase activity" | 13/18 | 1/0 | A2416T (rpoB) | - |
| Chan RCY JAC 2007 | CAC/CTC | 170 | 57 | His/Leu | 1994-2004 | Hong Kong | PCR-SSCP , Sequencing | Whole gene | Z | - | BACTEC MGIT 960 | 250 | 89 | - | - |
| Louw GE Int J Tuberc Lung Dis 2006 | del T | 172 | 58 | Frameshift | 2001-2002 | South Africa | Sequencing | Whole gene | ZHRSEthK | - | BACTEC MGIT 960 | 115 | 68 | - | ![]() |
| Escalante P TuberLung Dis 1998 | TTC/CTC | 172 | 58 | Phe/Leu | 1995-1996 | Peru | Sequencing | Whole gene | ZHR | - | Proportion method | 40146 | 1/0 | "katG, 315, AGC/ACC; rpoB, 526 cac/ctc; embB, 306, ATG/ATA " | - |
| Hirano K TLD 1997 | TTC/TTG | 174 | 58 | Phe/Leu | 1997 | Canada | Sequencing | Whole gene | ZHRS | 400 | Proportion method | 33/168 | 1/0 | - | - |
| Brown TJ JMedMicro 2000 | TCC/CCC | 175 | 59 | Ser/Pro | 2000 | Turkey | Sequencing | Whole gene | ZHRP | - | BACTEC 460 | 13/18 | 1/0 | C2431T (rpoB) | - |
Disclaimer: These are all putative mutations found in drug resistant clinical TB isolates. No a priori decisions have been made as to whether these mutations are causally related to resistance or possible secondary mutations. |
|
© 2010 Andreas Sandgren | Supported by the Swedish Research Council | Contact Database Curator |